A Case of Pediatric Pemphigus Treated with Rituximab – Our Experience
Valentina Broshtilova, Snejina Vassileva
Asian Journal of Research in Dermatological Science · pp. 21–26 · Published 17 Apr 2019
Abstract
Pemphigus vulgaris is an autoimmune blistering disease with great diagnostic and therapeutic challenge in the pediatric age group. The severe clinical course is often complicated with substantial morbidity and mortality, attributed to treatment side effects. Rituximab proves effective in cases unresponsive to conventional immunosuppressive therapy, corticosteroid-resistant patients and in those who experience unbearable and severe side effects. We present a recalcitrant case of juvenile pemphigus vulgaris treated with rituximab. Additionally, highlights of the currently reported cases of pediatric pemphigus, who received anti-CD20 monoclonal antibody therapy, are provided.
Cited by 0
No indexed citations yet.
Related research
- A Review on Pemphigus — shares topic coverage
- Case Report and Review of Pempigus Vulgaris — shares topic coverage
- Pemphigus and Plummer-Vinson Syndrome: An Uncommon Association — shares topic coverage
- Determination of Dermatology Life Quality Index Criteria in Libyan Pemphigus Patients — shares topic coverage
- Clinical and Evolutionary Characteristics of Pemphigus by Gender: Comparative Study of 330 Cases — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.